The Plant-based Expression Systems Market Size is valued at USD 235.71 Million in 2023 and is predicted to reach USD 408.3 Million by the year 2031 at a 7.28% CAGR during the forecast period for 2024-2031.
In recent years, the plant-based expression system has gained significant attention for its characteristics of high compatibility with culture media, safety, and low cost. Plant expression systems are a practical option for producing antibodies, vaccines, and complex biomolecules because of their advantages: lower prices, high flexibility to scale up, environment friendly, and low contamination risks.
Several factors such as the increasing chronic diseases, high requirement of the research process for protein expression, surging R&D initiatives for disease therapeutics, growing government funding for commercialization of plant expression technologies, and advancements in plant expression systems are expected to favour the development of the plant-based expression systems market during the forecast period. A wide range of pharmaceutical antibodies has been expressed in plants. Hence, plant-based protein expression systems are becoming more critical to scale production and meet market demands. However, the high costs of instruments and protein expression reagents may hinder the growth of the market.
Market Segmentation
The plant-based expression systems market is segmented into the product, plant, type of service, expression system, and region. By product, the market comprises biosimilars, cell therapies, gene therapies, monoclonal antibodies, vaccines, and others. The vaccines and monoclonal antibodies accounted for the largest market share in 2023, owing to the rising prevalence of cancer and cardiovascular diseases.
The market is classified into algae, barley, benth, duckweed, lettuce, maize, moss, rice, tomato, tobacco, and wheat germ in terms of the plant. The type of service segment is grouped into research and development, manufacturing, fill/finish, and others. By expression system, the market is divided into stable expression system and transient expression system. The transient expression system is expected to dominate the market in the upcoming years due to its benefits, such as producing high yield, environment friendly, scalability, uniformity and consistency of product accumulation. The market is being studied throughout North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America is projected to lead the plant-based expression systems market over the forecast years, followed by Asia-Pacific. The factors such as the fast adoption of advanced technologies, high demand for protein therapeutics, and the rising R&D investments in plant expression technologies.
Competitive Landscape
Some Of The Key Players In The Plant-based Expression Systems Market:
- Medicago
- Leaf Expression Systems
- Eleva
- iBIO
- Creative Biogene
- PlantForm
- Protalix BioTherapeutics, Inc.
- G+Flas Life Sciences
- Kentucky Bioprocessing
- Angany
- Stine Seed (ProdiGene Inc.)
- ORF Genetics
- Profacgen
- Phylloceuticals
- Cape Biologix Technologies (Cape Bio Pharms)
- CC-Pharming (Also known as Ruicheng Haihui Biotechnology)
- Calyxt
- CellFree Sciences Co.,Ltd.
- GenScript
- Icon Genetics GmbH
- Lifeasible
- Agrenvec S.L.
- ATB Therapeutics.
- Bright Biotech
- Other Prominent Players
Plant-based Expression Systems Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 235.71 Million |
|
Revenue Forecast In 2031 |
USD 408.3 Million |
|
Growth Rate CAGR |
CAGR of 7.28% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Plant, By Expression system, By Type of Service |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Medicago, Leaf Expression Systems, Eleva, iBIO, Creative Biogene, PlantForm, Protalix BioTherapeutics, Inc., G+Flas Life Sciences, Kentucky Bioprocessing, Angany, and others. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
